Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans
RECO1
1 other identifier
interventional
26
1 country
1
Brief Summary
First degree relatives of type 2 diabetic patients (T2DM) suffer an increased risk of developing this disease themselves, starting with impaired insulin sensitivity. This risk can be minimized by lifestyle interventions such as regular exercise training. Until this day, little is known about the short-term effects of exercise training on insulin sensitivity and the lipid content of the liver and skeletal muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes-mellitus
Started Feb 2006
Typical duration for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 30, 2008
CompletedFirst Posted
Study publicly available on registry
July 3, 2008
CompletedAugust 20, 2008
July 1, 2008
2.3 years
June 30, 2008
August 19, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ATP-Synthesis, liver lipid content, skeletal muscle lipid content
Interventions
3 bouts of exercise at 90%RCP during one week
Eligibility Criteria
You may qualify if:
- First degree relatives of type 2 diabetic patients
- Age: 18-50 years
- BMI \<30 kg/m2 (due to limited MR diameter)
- Normal routine lab tests (blood cell count, kidney, liver, pancreas, thyroid and neuromuscular function)
- Availability within the local area throughout the study
- Ability to understand and sign the consent forms
You may not qualify if:
- Current smoking
- Present drug treatment
- Regular exercise training
- Contraindications for MRS studies: claustrophobia and metalliferous implants
- Pregnancy
- HIV or Hepatitis
- Acute disease 2 weeks previous to the examination
- Heart disease
- Hypertension (RR\>140/95)
- Liver disease
- Kidney disease
- Pulmonary disease
- Thyroid disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Landsteiner Institutlead
- Mein Hanusch-Krankenhauscollaborator
- Karl-Landsteiner Institute for Endocrinology and Metabolismcollaborator
- Medical University of Viennacollaborator
- Lund University Hospitalcollaborator
- Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italycollaborator
Study Sites (1)
Landsteiner Institute
Vienna, Vienna, 1140, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael Roden, Prof.Dr.
Landsteiner Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 30, 2008
First Posted
July 3, 2008
Study Start
February 1, 2006
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
August 20, 2008
Record last verified: 2008-07